Validated Stability Indicating and Assay Method Development of Linagliptin in Formulation by RP-HPLC Using Quality by Design

Quality by Design (QbD) approach was used to facilitate stability indicating HPLC method development of linagliptin (LIN) in tablet dosage form. The method was developed using the PrimesilC18, 250 mm x 4.6 mm, 5µ column using the mobile phase consisting of 0.3% TEA: methanol. (60:40 v/v) pH 4.5 adju...

Full description

Bibliographic Details
Main Authors: Anvesha V. Ganorkar, Sonali S. Askarkar, Krishna R. Gupta, Milind J. Umekar
Format: Article
Language:English
Published: Universidade Federal de Mato Grosso do Sul 2020-06-01
Series:Orbital: The Electronic Journal of Chemistry
Subjects:
Online Access:https://periodicos.ufms.br/index.php/orbital/article/view/15745
_version_ 1828057870908784640
author Anvesha V. Ganorkar
Sonali S. Askarkar
Krishna R. Gupta
Milind J. Umekar
author_facet Anvesha V. Ganorkar
Sonali S. Askarkar
Krishna R. Gupta
Milind J. Umekar
author_sort Anvesha V. Ganorkar
collection DOAJ
description Quality by Design (QbD) approach was used to facilitate stability indicating HPLC method development of linagliptin (LIN) in tablet dosage form. The method was developed using the PrimesilC18, 250 mm x 4.6 mm, 5µ column using the mobile phase consisting of 0.3% TEA: methanol. (60:40 v/v) pH 4.5 adjusted with o-phosphoric acid. Design of experiment tools was used for optimization of the chromatographic conditions. A three-level Box-Behnken design was employed and statistical analysis of the experimental data showed the significant influential factor of chromatographic conditions. The design space suggested that the current center point parameters could be further modified results with better acceptability for the response parameters. The performance of the optimized method was validated according to ICH guidelines.  Linagliptin was exposed to different stress conditions (acid, base, neutral, oxidative, thermal and photolytic) and chromatograms recorded at 292 nm. The degradation of linagliptin followed zero order kinetics for acidic, oxidative and neutral hydrolysis whereas for basic hydrolysis first-order kinetics under experimental conditions. Peak purity plots were evaluated for the degraded sample. The results obtained suggest that the method can be adopted for its analysis and is stability indicating as well. The three-level design helps in understanding the interaction among factors rather than one time one variation as carried out in routine method development. DOI: http://dx.doi.org/10.17807/orbital.v12i2.1194
first_indexed 2024-04-10T21:17:58Z
format Article
id doaj.art-e361627d57a149ad9029e931d14be9ef
institution Directory Open Access Journal
issn 1984-6428
language English
last_indexed 2024-04-10T21:17:58Z
publishDate 2020-06-01
publisher Universidade Federal de Mato Grosso do Sul
record_format Article
series Orbital: The Electronic Journal of Chemistry
spelling doaj.art-e361627d57a149ad9029e931d14be9ef2023-01-20T10:50:50ZengUniversidade Federal de Mato Grosso do SulOrbital: The Electronic Journal of Chemistry1984-64282020-06-01122Validated Stability Indicating and Assay Method Development of Linagliptin in Formulation by RP-HPLC Using Quality by DesignAnvesha V. Ganorkar0Sonali S. Askarkar1Krishna R. Gupta2Milind J. Umekar3Smt Kishoritai Bhoyar College of Pharmacy, Behind Railway Station, New kamptee, NagpurSmt Kishoritai Bhoyar College of Pharmacy, Behind Railway Station, New kamptee, NagpurSmt Kishoritai Bhoyar College of Pharmacy, Behind Railway Station, New kamptee, NagpurSmt Kishoritai Bhoyar College of Pharmacy, Behind Railway Station, New kamptee, NagpurQuality by Design (QbD) approach was used to facilitate stability indicating HPLC method development of linagliptin (LIN) in tablet dosage form. The method was developed using the PrimesilC18, 250 mm x 4.6 mm, 5µ column using the mobile phase consisting of 0.3% TEA: methanol. (60:40 v/v) pH 4.5 adjusted with o-phosphoric acid. Design of experiment tools was used for optimization of the chromatographic conditions. A three-level Box-Behnken design was employed and statistical analysis of the experimental data showed the significant influential factor of chromatographic conditions. The design space suggested that the current center point parameters could be further modified results with better acceptability for the response parameters. The performance of the optimized method was validated according to ICH guidelines.  Linagliptin was exposed to different stress conditions (acid, base, neutral, oxidative, thermal and photolytic) and chromatograms recorded at 292 nm. The degradation of linagliptin followed zero order kinetics for acidic, oxidative and neutral hydrolysis whereas for basic hydrolysis first-order kinetics under experimental conditions. Peak purity plots were evaluated for the degraded sample. The results obtained suggest that the method can be adopted for its analysis and is stability indicating as well. The three-level design helps in understanding the interaction among factors rather than one time one variation as carried out in routine method development. DOI: http://dx.doi.org/10.17807/orbital.v12i2.1194 https://periodicos.ufms.br/index.php/orbital/article/view/15745assayBox-Behnken designlinagliptinstability indicatingvalidation
spellingShingle Anvesha V. Ganorkar
Sonali S. Askarkar
Krishna R. Gupta
Milind J. Umekar
Validated Stability Indicating and Assay Method Development of Linagliptin in Formulation by RP-HPLC Using Quality by Design
Orbital: The Electronic Journal of Chemistry
assay
Box-Behnken design
linagliptin
stability indicating
validation
title Validated Stability Indicating and Assay Method Development of Linagliptin in Formulation by RP-HPLC Using Quality by Design
title_full Validated Stability Indicating and Assay Method Development of Linagliptin in Formulation by RP-HPLC Using Quality by Design
title_fullStr Validated Stability Indicating and Assay Method Development of Linagliptin in Formulation by RP-HPLC Using Quality by Design
title_full_unstemmed Validated Stability Indicating and Assay Method Development of Linagliptin in Formulation by RP-HPLC Using Quality by Design
title_short Validated Stability Indicating and Assay Method Development of Linagliptin in Formulation by RP-HPLC Using Quality by Design
title_sort validated stability indicating and assay method development of linagliptin in formulation by rp hplc using quality by design
topic assay
Box-Behnken design
linagliptin
stability indicating
validation
url https://periodicos.ufms.br/index.php/orbital/article/view/15745
work_keys_str_mv AT anveshavganorkar validatedstabilityindicatingandassaymethoddevelopmentoflinagliptininformulationbyrphplcusingqualitybydesign
AT sonalisaskarkar validatedstabilityindicatingandassaymethoddevelopmentoflinagliptininformulationbyrphplcusingqualitybydesign
AT krishnargupta validatedstabilityindicatingandassaymethoddevelopmentoflinagliptininformulationbyrphplcusingqualitybydesign
AT milindjumekar validatedstabilityindicatingandassaymethoddevelopmentoflinagliptininformulationbyrphplcusingqualitybydesign